Global Liver Institute, Einstein-Montefiore CCPD, and Integritas Communications Receive Educational Grant from Pfizer to Hold 2021 NASH Diagnostics Forum™
Findings to Be Shared Through a CME/CE-Certified Webcast, Peer-Reviewed Article, and Online Resource Center
(Washington, D.C., November 9, 2020) – Global Liver Institute (GLI), Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development (Einstein-Montefiore), and Integritas Communications (Integritas) have received an educational grant from Pfizer, Inc., to execute the 2021 Nonalcoholic Steatohepatitis (NASH) Diagnostics Forum™. The initiative, titled “A Critical Appraisal of Noninvasive Technologies in NASH: Informing the Future of NASH Diagnosis and Assessment,” will convene a multidisciplinary panel of experts to conduct a comprehensive analysis of available data on noninvasive biomarkers and tools for diagnosis, prognosis, and monitoring of NASH, the advanced form of nonalcoholic fatty liver disease (NAFLD). The grant will also support dissemination of the Forum’s findings to the broader medical community via multiple media.
Eight international NASH experts from the fields of hepatology and endocrinology will convene in the first quarter of 2021 to analyze key scientific information related to advancements and current best practices surrounding the diagnosis of NASH. GLI, Einstein-Montefiore, and Integritas will develop a short-segment continuing medical education webcast highlighting the key goals, findings, and output of the NASH Diagnostics Forum™. The webcast will be disseminated via the Reach MD network to a broad national and international audience of hepatology, gastroenterology, and endocrinology specialists, and other clinicians who treat patients with, or at risk of, NASH. Additionally, the educational partners will conduct a field survey to determine the clinical practice patterns and opinions of specialists involved in the care of patients with NASH for comparison with the evidence-based findings and recommendations of the Forum panel. The initiative’s full findings will be compiled for inclusion in a peer-reviewed publication in the third quarter of 2021.
“Comprehensive, global engagement is imperative to expanding the adoption of noninvasive diagnostics for liver disease and helping us move ‘beyond the biopsy,’” stated Donna Cryer, JD, president and CEO of GLI. “We’re grateful to have the opportunity to convene international NASH experts and share our findings with clinicians, patient advocates, and the full NASH community. Noninvasive tools, such as blood tests and imaging, are key to scaling safe, effective methods for diagnosis, monitoring, and improving the health of the 148 million people with NASH worldwide and those at high risk, such as people living with obesity or type 2 diabetes. We’ll continue to advocate for the development and use of these essential tools through our Beyond the Biopsy initiative, the GLI NASH Council, and International NASH Day on June 10, 2021.”
“This initiative fits into our current scope of work, delivering activities that improve clinicians’ knowledge, skills, strategies, clinical performance, and patient outcomes. We collaborate with our healthcare professionals to develop interprofessional education that improves patient care,” notes Victor Hatcher, PhD, Associate Dean of Albert Einstein College of Medicine. Albert Einstein College of Medicine-Montefiore Medical Center offers continuing education credit for dentistry, medicine, nursing, optometry, pharmacy, physician assistants, psychology, and social work.
“As an educational provider, it is this type of initiative that we—and our contributing faculty members—find most meaningful and impactful. Our program design allows for an in-depth appraisal of evidence and provides a means to identify gaps in clinical practice relative to evidence-based recommendations,” shares Becky Carney, Sr. Vice President of Educational Strategy at Integritas Communications.
GLI works to improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and supporting the scaling of optimal approaches to help eradicate liver diseases, including NASH. Visit the GLI website to:
Read more information on Beyond the Biopsy, a GLI initiative to promote the use of and education about noninvasive diagnostics as an alternative to biopsies. View the Beyond the Biopsy Summary Report September 2020 [PDF].
Download resources on NASH and sign up for our NASH News monthly newsletter.
Join the GLI NASH Council, a collaborative group with representatives from non-profit, for-profit, and government.
Apply for the Advanced Advocacy Academy (A3), a GLI program for liver patients and family members.
Learn more about International NASH Day, to be held next year on June 10, 2021.
###
For more information contact:
Whitney Gray, GLI
wgray@globalliver.org
About Global Liver Institute
Global Liver Institute (GLI) is a 501(c)(3) tax-exempt not-for-profit organization, headquartered in Washington, D.C., United States, with offices in the U.S. and Europe. GLI's vision is for liver health to take its place on the global public health agenda commensurate with its prevalence and impact. GLI's mission is to improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and supporting the scaling of optimal approaches to help eradicate liver diseases. For more information, visit www.GlobalLiver.org. Follow us on Twitter, Facebook, Instagram, and LinkedIn.
About the Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development
Einstein-Montefiore is a 501(c)(3) tax-exempt not-for-profit organization located in New York City. Einstein-Montefiore is committed to the utilization of resources for the advancement of continuing medical education throughout the clinician’s professional career. Their mission is to enhance patient care by bringing diagnostic and therapeutic innovations to the clinical environment through professional medical education for clinicians. View more information at www.einstein.yu.edu/education/continuing-medical-education/.
About Integritas Communications
As professionals dedicated to the creation of scientifically accurate, clinically relevant, and appropriately balanced CME and CE programs, members of Integritas Communications have extensive experience educating clinicians in a range of therapeutic areas, including NASH and type 2 diabetes mellitus. In the last few years, our educational-strategy and scientific professionals have participated in the development of educational programming for meetings of the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, the Infectious Diseases Society of America, Digestive Diseases Week, and the American College of Gastroenterology. Integritas has also worked in conjunction with Sanjeev Arora, MD, and the Project ECHO (Extension for Community Healthcare Outcomes) program. Learn more at http://integritasgrp.com/.